Recent Posts

RT @RetinalPhys: Suprachoroidal Gene Transfer: A noninvasive approach to transdu…

[ad_1] RT @RetinalPhys: Suprachoroidal Gene Transfer: A noninvasive approach to transduce photoreceptors and retinal pigment epithelium. By Peter… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

RT @IllinoisRetina: Dr. MacCumber recently moderated a session on Gene Therapy a…

[ad_1] RT @IllinoisRetina: Dr. MacCumber recently moderated a session on Gene Therapy and presented at the 43rd Macula Society meeting in San Dieg… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Just presented at ARVO: Pharmacokinetics and Ocular Tolerability of Suprachoroid…

[ad_1]

Just presented at ARVO:
Pharmacokinetics and Ocular Tolerability of Suprachoroidal CLS-AX (axitinib injectable suspension) in rabbits | IOVS | ARVO Journals https://t.co/h81HLca3O8

#retina #eyes #ophthalmology #ophthalmologist #optometry https://t.co/cLfEdT0Jgx
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

RNA therapy has generated great interest in the broader medical community, after…

[ad_1] RNA therapy has generated great interest in the broader medical community, after approvals for devastating systemic disorders such as spinal muscular atrophy and Duchenne muscular dystrophy … https://t.co/IASbx4uC1n [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

RT @OTEurope: How DME patients may fare differently in ‘real world’ versus trial…

[ad_1] RT @OTEurope: How DME patients may fare differently in ‘real world’ versus trials https://t.co/JX7GnmUcc8 https://t.co/FinpM6swPf [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Our paper reporting the first successful phase 3 clinical trial for Suprachoroid…

[ad_1]
Our paper reporting the first successful phase 3 clinical trial for Suprachoroidal Delivery came out in this month’s issue of Ophthalmology. https://t.co/vsNrOm4F8v
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

ARVO meeting abstract just published: Ocular Pharmacokinetics and Safety of Supr…

[ad_1] ARVO meeting abstract just published: Ocular Pharmacokinetics and Safety of Suprachoroidal A01017, Small Molecule Complement Inhibitor, Injectable Suspension in Rabbits | IOVS | ARVO Journals https://t.co/FC85W5jD07 #retina #eyes #ophthalmology #optometry From Danobeiti 2014: https://t.co/mr49Lnel35 [ad_2] Source by Thomas Ciulla, MD, MBA Return to main 

Just presented at ARVO: Suprachoroidal CLS-AX (axitinib injectable suspension)…

[ad_1] Just presented at ARVO: Suprachoroidal CLS-AX (axitinib injectable suspension), as a Potential Long-Acting Therapy for Neovascular Age-Related Macular Degeneration (nAMD) | IOVS | ARVO Journals https://t.co/OigBzx215J #retina #eyes #ophthalmology #ophthalmologist #optometry https://t.co/WWv4RJYvGk [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Area of Disorganization of the Retinal Inner Layers (DRIL) as a Quantitative Bio…

[ad_1]

Area of Disorganization of the Retinal Inner Layers (DRIL) as a Quantitative Biomarker in Eyes with Diabetic Macular Edema | IOVS | ARVO Journals https://t.co/SKQVHzDbra

#retina #eyes #ophthalmology #ophthalmologist #oftalmologia #optometry https://t.co/cHOafj2fAA
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

Treatment Burden and Visual Outcomes in Neovascular Age-Related Macular Degenera…

[ad_1] Treatment Burden and Visual Outcomes in Neovascular Age-Related Macular Degeneration (AMD) | IOVS | ARVO Journals https://t.co/y3AGPDf6un [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.